Clinical Trial: A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07610278) titled 'A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia' on May 20.

Brief Summary: This is a multicenter, randomized, double-blind, factorial design Phase 2 study to evaluate the pharmacodynamics, safety and tolerability of a combination of QCZ484 and inclisiran compared to QCZ484, inclisiran, and placebo in participants with hypertension and concomitant hypercholesterolemia.

Study Start Date: June 03

Study Type: INTERVENTIONAL

Condition: Hypercholesterolaemia

Intervention: DRUG: QCZ484

QCZ484 once on Day 1

DRUG: Inclisiran

Incl...